Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial
Maktoob - 2/3/2026 7:18:52 PM - GMT (+3 )
Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial

read more
Business More
Sports More